SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 35.11 |
| Enterprise Value ($M) | 45.97 |
| Book Value ($M) | 55.08 |
| Book Value / Share | 1.41 |
| Price / Book | 0.64 |
| NCAV ($M) | 36.62 |
| NCAV / Share | 0.94 |
| Price / NCAV | 0.96 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.25 |
| Return on Assets (ROA) | -0.18 |
| Return on Equity (ROE) | -0.29 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.00 |
| Current Ratio | 3.00 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 72.18 |
| Assets | 90.64 |
| Liabilities | 35.57 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 3.75 |
| Operating Income | -37.12 |
| Net Income | -21.29 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -24.01 |
| Cash from Investing | 6.15 |
| Cash from Financing | -0.14 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Avidity Partners Management LP | 9.90 | 0.83 | |
| 13G/A | Federated Hermes, Inc. | 15.50 | -9.82 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 37,951 | 144,965 | 26.18 | |
| 31,199 | 143,899 | 21.68 | |
| 9,248 | 28,232 | 32.76 | |
| 3,098 | 29,545 | 10.49 | |
| 5,881 | 121,955 | 4.82 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RNAC – Cartesian Therapeutics, Inc. | RYTM – Rhythm Pharmaceuticals, Inc. |
| SAGE – Sage Therapeutics, Inc. | SGMT – Sagimet Biosciences Inc. |
| SIGA – SIGA Technologies, Inc. |